2022
DOI: 10.1017/s1047951122002530
|View full text |Cite
|
Sign up to set email alerts
|

Serum endocan levels in children with rheumatic aortic insufficiency: can it differentiate bicuspid aortic valve disease from rheumatic heart disease?

Abstract: Aim: In this study, it was aimed to examine the serum endocan levels in patients with rheumatic aortic regurgitation and to investigate whether it has a value in differentiating it from aortic regurgitation due to bicuspid aortic valve. Methods: Blood samples were collected from patients with rheumatic aortic regurgitation (Group 1), incidentally diagnosed patients with borderline or definite rheumatic aortic regurgitation (Group 2), children with bicuspid aortic valve accompanied by aor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…They found endocan acceptable for prediction of death (AUC = .61 [.55–.67]) and major disability defined by modified Rankin Scale score ≥3 (AUC = .68 [.59–.76]). In another study, Laloğlu et al 39 found that endocan levels can differentiate between rheumatic aortic regurgitation and non-rheumatic aortic regurgitation.…”
Section: Discussionmentioning
confidence: 97%
“…They found endocan acceptable for prediction of death (AUC = .61 [.55–.67]) and major disability defined by modified Rankin Scale score ≥3 (AUC = .68 [.59–.76]). In another study, Laloğlu et al 39 found that endocan levels can differentiate between rheumatic aortic regurgitation and non-rheumatic aortic regurgitation.…”
Section: Discussionmentioning
confidence: 97%